Enorama Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	101	203	114	28	171	195
Market Cap Growth	-44.66%	77.51%	308.04%	-83.60%	-12.51%	-12.75%
Enterprise Value	95	194	108	27	171	197
Last Close Price	1.35	3.36	2.51	2.95	17.98	26.75
PS Ratio	27.84	12.89	84.29	4.10	13.36	43.74
PB Ratio	-21.74	26.04	5.86	0.89	8.01	110.00
P/TBV Ratio	-	26.04	5.86	0.89	8.01	110.00
EV/Sales Ratio	26.03	12.30	79.67	3.88	13.39	44.18
Debt / Equity Ratio	-	-	0.02	0.06	0.18	3.21
Asset Turnover	0.13	0.63	0.03	0.14	0.28	0.11
Inventory Turnover	2.71	1.55	1.48	3.66	6.03	-
Quick Ratio	0.46	0.43	0.80	0.68	1.77	0.59
Current Ratio	0.71	1.87	1.27	0.95	1.92	0.69
Return on Equity (ROE)	-526.84%	-320.44%	-174.74%	-158.97%	-239.87%	-523.81%
Return on Assets (ROA)	-163.56%	-118.33%	-62.91%	-52.64%	-37.20%	-34.45%
Return on Capital Employed (ROCE)	1523.30%	-610.00%	-173.10%	-115.60%	-69.60%	-103.20%
Earnings Yield	-75.76%	-21.56%	-38.97%	-149.82%	-16.22%	-12.00%
FCF Yield	-	-17.57%	-36.12%	-117.48%	-17.67%	-12.54%
Buyback Yield / Dilution	-37.91%	-91.50%	-253.96%	-26.23%	-11.44%	-3.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.